Development of an in vitro test procedure for the characterization of left atrial appendage occluder devices

The implantation of an occluder in the left atrial appendage (LAA) is an emerging therapy for the treatment of patients suffering from atrial fibrillation and with a contraindication to oral anticoagulation. The LAA occluder (LAAO) provides a reduction of the potential risk of strokes by thromboembo...

Full description

Bibliographic Details
Main Authors: Borowski Finja, Kaule Sebastian, Siewert Stefan, Schmitz Klaus-Peter, Stiehm Michael, Öner Alper Ö, Grabow Niels
Format: Article
Language:English
Published: De Gruyter 2019-09-01
Series:Current Directions in Biomedical Engineering
Subjects:
Online Access:https://doi.org/10.1515/cdbme-2019-0116
id doaj-813b57d5863d4ed0a584f4dd003794d9
record_format Article
spelling doaj-813b57d5863d4ed0a584f4dd003794d92021-09-06T19:19:27ZengDe GruyterCurrent Directions in Biomedical Engineering2364-55042019-09-015146146310.1515/cdbme-2019-0116cdbme-2019-0116Development of an in vitro test procedure for the characterization of left atrial appendage occluder devicesBorowski Finja0Kaule Sebastian1Siewert Stefan2Schmitz Klaus-Peter3Stiehm Michael4Öner Alper Ö5Grabow Niels6Schmitz Klaus-Peter7Institute for ImplantTechnology and Biomaterials e.V., Friedrich-Barnewitz- Straße 4, Rostock-Warnemünde, GermanyInstitute for ImplantTechnology and Biomaterials e.V., Rostock-Warnemünde, GermanyInstitute for ImplantTechnology and Biomaterials e.V., Rostock-Warnemünde, GermanyInstitute for ImplantTechnology and Biomaterials e.V., Rostock-Warnemünde, GermanyInstitute for ImplantTechnology and Biomaterials e.V., Rostock-Warnemünde, GermanyDepartment of Cardiology Rostock University Medical Center,Rostock, GermanyInstitute for Biomedical Engineering, Rostock University Medical Center,Rostock, GermanyInstitute for Biomedical Engineering, Rostock University Medical Center,Rostock, GermanyThe implantation of an occluder in the left atrial appendage (LAA) is an emerging therapy for the treatment of patients suffering from atrial fibrillation and with a contraindication to oral anticoagulation. The LAA occluder (LAAO) provides a reduction of the potential risk of strokes by thromboembolism. Currently, only a few CE-approved devices are available on the market and the number of clinical trials is comparatively low. Furthermore, there is currently no standardized test method available for testing functionality of the occluder, especially for testing safe anchorage and permeability. Therefore, the aim of this study is to establish an in vitro test method to prove anchorage mechanism and permeability regarding thromboembolism of the LAAO under physiological conditions. A standardized technical and fully parameterized silicone model of a LAA, based on studies of different morphologies and sizes, was developed. The LAA model was mounted onto the left atrial chamber of a commercial pulse duplicator system to simulate physiological hemodynamic conditions. The test was performed using the Watchman device (Boston Scientific, USA; size: 31 mm). The inner implantation diameter of the LAA model was designed according to a target compression of 10% for the Watchman device in the implanted configuration. Furthermore, thrombus-like particles (n=150, d=1,7±0,05 mm) were added to represent the flushing of thrombi out of the LAA after device implantation. Within several cycles it was confirmed that no particles were washed out of the LAA model with the implanted occluder leading to a full protection against thromboembolism. It could also be shown that the occluder is firmly anchored in the LAA. Pressure measurements with sensors in the left atrium and in the LAA distal to the occluder could also show that the occluder has no influence on the pressure conditions in the LAA.https://doi.org/10.1515/cdbme-2019-0116laa occlusionin vitro testing
collection DOAJ
language English
format Article
sources DOAJ
author Borowski Finja
Kaule Sebastian
Siewert Stefan
Schmitz Klaus-Peter
Stiehm Michael
Öner Alper Ö
Grabow Niels
Schmitz Klaus-Peter
spellingShingle Borowski Finja
Kaule Sebastian
Siewert Stefan
Schmitz Klaus-Peter
Stiehm Michael
Öner Alper Ö
Grabow Niels
Schmitz Klaus-Peter
Development of an in vitro test procedure for the characterization of left atrial appendage occluder devices
Current Directions in Biomedical Engineering
laa occlusion
in vitro testing
author_facet Borowski Finja
Kaule Sebastian
Siewert Stefan
Schmitz Klaus-Peter
Stiehm Michael
Öner Alper Ö
Grabow Niels
Schmitz Klaus-Peter
author_sort Borowski Finja
title Development of an in vitro test procedure for the characterization of left atrial appendage occluder devices
title_short Development of an in vitro test procedure for the characterization of left atrial appendage occluder devices
title_full Development of an in vitro test procedure for the characterization of left atrial appendage occluder devices
title_fullStr Development of an in vitro test procedure for the characterization of left atrial appendage occluder devices
title_full_unstemmed Development of an in vitro test procedure for the characterization of left atrial appendage occluder devices
title_sort development of an in vitro test procedure for the characterization of left atrial appendage occluder devices
publisher De Gruyter
series Current Directions in Biomedical Engineering
issn 2364-5504
publishDate 2019-09-01
description The implantation of an occluder in the left atrial appendage (LAA) is an emerging therapy for the treatment of patients suffering from atrial fibrillation and with a contraindication to oral anticoagulation. The LAA occluder (LAAO) provides a reduction of the potential risk of strokes by thromboembolism. Currently, only a few CE-approved devices are available on the market and the number of clinical trials is comparatively low. Furthermore, there is currently no standardized test method available for testing functionality of the occluder, especially for testing safe anchorage and permeability. Therefore, the aim of this study is to establish an in vitro test method to prove anchorage mechanism and permeability regarding thromboembolism of the LAAO under physiological conditions. A standardized technical and fully parameterized silicone model of a LAA, based on studies of different morphologies and sizes, was developed. The LAA model was mounted onto the left atrial chamber of a commercial pulse duplicator system to simulate physiological hemodynamic conditions. The test was performed using the Watchman device (Boston Scientific, USA; size: 31 mm). The inner implantation diameter of the LAA model was designed according to a target compression of 10% for the Watchman device in the implanted configuration. Furthermore, thrombus-like particles (n=150, d=1,7±0,05 mm) were added to represent the flushing of thrombi out of the LAA after device implantation. Within several cycles it was confirmed that no particles were washed out of the LAA model with the implanted occluder leading to a full protection against thromboembolism. It could also be shown that the occluder is firmly anchored in the LAA. Pressure measurements with sensors in the left atrium and in the LAA distal to the occluder could also show that the occluder has no influence on the pressure conditions in the LAA.
topic laa occlusion
in vitro testing
url https://doi.org/10.1515/cdbme-2019-0116
work_keys_str_mv AT borowskifinja developmentofaninvitrotestprocedureforthecharacterizationofleftatrialappendageoccluderdevices
AT kaulesebastian developmentofaninvitrotestprocedureforthecharacterizationofleftatrialappendageoccluderdevices
AT siewertstefan developmentofaninvitrotestprocedureforthecharacterizationofleftatrialappendageoccluderdevices
AT schmitzklauspeter developmentofaninvitrotestprocedureforthecharacterizationofleftatrialappendageoccluderdevices
AT stiehmmichael developmentofaninvitrotestprocedureforthecharacterizationofleftatrialappendageoccluderdevices
AT oneralpero developmentofaninvitrotestprocedureforthecharacterizationofleftatrialappendageoccluderdevices
AT grabowniels developmentofaninvitrotestprocedureforthecharacterizationofleftatrialappendageoccluderdevices
AT schmitzklauspeter developmentofaninvitrotestprocedureforthecharacterizationofleftatrialappendageoccluderdevices
_version_ 1717778512330358784